Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 16 | 19 | 18 | 18 | 18 |
| Accounts receivable | -24 | -110 | -42 | -13 | 64 |
| Other Working Capital | -222 | 73 | -1,411 | -146 | 498 |
| Other Operating Activity | -492 | -805 | -560 | -527 | -492 |
| Operating Cash Flow | $-721 | $-823 | $-1,996 | $-668 | $87 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21 | -15 | 0 | 19 | 0 |
| Investing Cash Flow | $-21 | $-15 | $0 | $19 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,000 | 0 | -15 | -124 | -5 |
| Debt Repayment | -15 | -3 | -7 | -5 | -8 |
| Common Stock Issued | N/A | 0 | 4,215 | N/A | N/A |
| Other Financing Activity | -160 | -7 | -247 | 779 | 0 |
| Financing Cash Flow | $1,825 | $-10 | $3,945 | $649 | $-13 |
| Exchange Rate Effect | 5 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 1,232 | 2,080 | 131 | 131 | 57 |
| End Cash Position | 2,321 | 1,232 | 2,080 | 131 | 131 |
| Net Cash Flow | $1,083 | $-849 | $1,949 | $-1 | $75 |
| Free Cash Flow | |||||
| Operating Cash Flow | -721 | -823 | -1,996 | -668 | 87 |
| Capital Expenditure | -21 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -742 | -823 | -1,996 | -668 | 87 |